June - 2011
| Next | Showing Journal 1 of 7 |
Randomized, Placebo-Controlled Clinical Trial of an Aerosolized Beta-2 Agonist for Treatment of Acute Lung InjuryMichael A. Matthay, Roy G Brower, Shannon Carson et al American Journal of Respiratory and Critical Care Medicine, 2011, published on line, March 2011 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
June |
Previous Comments
No Comments yet.
Comment
Despite preliminary data that suggested beta agonist salbutamol increases the resolution of lung oedema, there was no evidence in this well conducted study that outcomes in ARDS are improved.